HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. - Wikidata - awgldk - TriplyDB

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

http://www.wikidata.org/entity/Q33578883

about

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants Chronic arthritis in children and adolescents in two Indian health service user populations Leukocyte Ig-Like Receptors - A Model for MHC Class I Disease Associations Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci.Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis.HLA-B27: natural function and pathogenic role in spondyloarthritis.Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican subjects with ankylosing spondylitis.Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis Identification of Disease-Promoting HLA Class I and Protective Class II Modifiers in Japanese Patients with Familial Mediterranean Fever.Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.Inflammatory bowel disease associated arthropathy An update on the contribution of the MHC to AS susceptibility.Gut microbiota amplifies host-intrinsic conversion from the CD8 T cell lineage to CD4 T cells for induction of mucosal immune tolerance.Enteropathic spondyloarthritis: from diagnosis to treatment.Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis Ankylosing spondylitis: from cells to genes The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09.Genetics of rheumatic disease.Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis.Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?Making sense of the cause of Crohn's - a new look at an old disease.rs657075 (CSF2) Is Associated with the Disease Phenotype (BAS-G) of Ankylosing Spondylitis Prevalence of HLA-B27 in the New Zealand population: effect of age and ethnicity.Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity.The joint-gut axis in inflammatory bowel diseases.Extraintestinal manifestations and complications in IBD.Symptom management in inflammatory bowel disease.The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment.Occult spondyloarthritis in inflammatory bowel disease.Pathogenesis of ankylosing spondylitis - recent advances and future directions.New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications.Autoinflammation and HLA-B27: Beyond Antigen Presentation.The D0 Ig-like domain plays a central role in the stronger binding of KIR3DL2 to B27 free H chain dimers.Prevalence of HLA-B27 antigen in patients with juvenile idiopathic arthritis.New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease.High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.

P2860

Q24646663-1592751A-ABF0-47DF-97E3-22438BAA69A9 Q24793281-96EA419D-4F1F-4E8F-9F54-788B9F35787F Q26738439-29CC2E0D-3372-4216-876A-C72C9633314F Q29417082-4C89AD9A-D3B5-461D-96CF-ED3328705B6F Q34114676-9353587B-30BC-4B68-8CE5-DD1BF0B85E9A Q34265730-20FA5D64-335C-4379-BCFF-A46638EE8E77 Q34731174-BA8C7210-0A34-4552-9036-E855BDFA27FD Q35349708-E23E27FC-5CD1-45F5-9860-C5E176015DD4 Q35547393-C3CBB455-40F0-4C76-B782-A866672AD4E0 Q35548958-CC5DFC9A-E297-4507-8AD9-8ABC0A8E679F Q35606855-0B67AB28-F547-43F6-963C-C103E50AD525 Q35645174-6200AA90-9BE7-49C2-A4A6-929B2F089E14 Q35670468-F1EE1674-4602-46ED-B224-CBE774E1F0F5 Q35680638-EA29B453-DF24-440D-B92F-9106145D399F Q35809280-8948C366-C23E-4395-912A-9DE8F93E8C75 Q35945238-3373164C-BE1E-4A11-A3F3-8AE172A16A0E Q36830824-000F532D-A305-406C-8711-5D7A842799F8 Q36866358-6707408B-2F85-46E0-8E9B-D369C790D242 Q37076771-CDA6D41C-37A6-4951-867B-15B3F825E2CA Q37077734-C275185F-01E9-480A-8609-A9F9DA42619E Q37234677-612C1E22-A36E-467F-843A-E65664A2873D Q37453992-B0827715-F1AB-4F1E-AD1E-51FA8A0C4C8F Q37454085-979D4A5E-FC1F-40C6-ACD9-4376A6EEFF3C Q37495746-719F2DE1-8D1D-4DA6-9118-0BB465147AA7 Q37577712-123C67E7-682E-4E88-AE33-845438DCECFD Q37631508-474B954C-2154-4455-BE0F-52590A0C02D5 Q37690183-FEF20641-383E-4AC1-88D2-AC6B86C2D3B3 Q37693227-8C67C881-6CC6-4E1F-B1A7-03A00167461E Q37814551-F08E3BD9-BD0B-4DB6-B220-CDC5D3A32ACE Q38120146-2B281645-9081-4C27-8EF8-DFCEAD2E4657 Q38438128-F12EA870-EC24-485B-AE08-D944904DB415 Q38529525-5A7CDF27-70A1-46C3-96A9-9ACDEB3F4721 Q38583788-59665B01-DC95-49C8-AFAA-63F068CC23AC Q38690443-D5D73FC8-9C4F-48A2-8DF6-F20C3F8BE730 Q38840984-F9051702-B128-4ADE-85B0-939E175217CF Q38845301-E3F82985-DF14-4609-AA5B-DB407330A33E Q38920594-024D0527-3673-4AF5-9D92-A48902D6538B Q40696741-7CBE790E-44E7-4185-A66F-42541A0CD5FC Q41111557-49C427C5-3D7F-4A16-AD8C-AF0506CBB1D1 Q41410124-0224050B-5C21-4CA5-B280-B48ADEACAA41

P2860

HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom.

http://www.wikidata.org/entity/Q33578883

description

1996 nî lūn-bûn

@nan

1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年学术文章

@wuu

1996年学术文章

@zh-cn

1996年学术文章

@zh-hans

1996年学术文章

@zh-my

1996年学术文章

@zh-sg

1996年學術文章

@yue

name

HLA class I associations of an ...... ulation in the United Kingdom.

@ast

HLA class I associations of an ...... ulation in the United Kingdom.

@en

HLA class I associations of an ...... ulation in the United Kingdom.

@nl

type

label

HLA class I associations of an ...... ulation in the United Kingdom.

@ast

HLA class I associations of an ...... ulation in the United Kingdom.

@en

HLA class I associations of an ...... ulation in the United Kingdom.

@nl

prefLabel

HLA class I associations of an ...... ulation in the United Kingdom.

@ast

HLA class I associations of an ...... ulation in the United Kingdom.

@en

HLA class I associations of an ...... ulation in the United Kingdom.

@nl

P1433

Q33578883-F947160C-4425-4CAF-AB0E-BD1AEECBE903

P1476

Q33578883-80CB2CCC-3A65-469A-B0CC-34FA5B929EE2

P2093

Q33578883-16787874-885A-4E97-972E-68B52D326376

Q33578883-342F7BE9-40D6-44F2-A87F-1372F328658B

Q33578883-6D11CD19-CE9F-4E77-B511-3671056BB7FB

Q33578883-78026475-0FC4-49F9-8974-28E4B79FCAEE

Q33578883-7E446E62-516A-463E-A45A-099374C9DA91

Q33578883-929502F9-6C8B-42D0-9BEA-3F181DFEAEBD

Q33578883-ADA9D586-37A9-4175-B559-4DBD9A2FD690

P2860

Q33578883-07F4C3C8-2F0C-4B2E-8659-44F25A2AD938

Q33578883-3F8CA08A-F658-43D1-945B-A7ACC3579C4F

Q33578883-453AF54F-B4C1-4161-804E-5565E114BBAC

Q33578883-4FC2336D-0EF2-4B66-B763-24E360F178DC

Q33578883-68B322BC-69B0-4966-9D61-309BE86217DB

Q33578883-8D01486C-E99B-4462-ABE7-57FF3D7EAC96

Q33578883-C8D6586C-C479-40A4-8F16-82C4913EB9B0

Q33578883-D10D89EF-1094-42FE-A5CB-9DDD7A7C4E16

Q33578883-DF968CA3-17F7-464B-83E2-6AF583274671

P304

Q33578883-BDD5388D-BEDF-4872-B341-276B56F992C6

P31

Q33578883-F7D161A3-67EC-48B1-BD13-64F27522428E

P356

Q33578883-7FA819A1-175D-4684-BF8B-27F128D70653

P407

Q33578883-6B5AF5CA-4354-4190-9143-7D00D94E7076

P433

Q33578883-B49FB4A7-7DA0-443C-BF0B-D2FCEED53BF1

P478

Q33578883-94E4EA2A-DE13-4C99-844A-BA67A3CF8190

P50

Q33578883-535BC6A0-1F36-4F48-B64A-FBAFDD9CEA2B

P577

Q33578883-8592594D-2F8B-4A00-8108-4860C39D9FC9

P5875

Q33578883-504B864A-37CA-4C52-9847-A66B5160578F

P698

Q33578883-B19E9DEB-9115-42EC-A383-1204EE2ECECB

P932

Q33578883-5C9D16F4-AA3A-4EEB-A3DA-30F6ACDE40EA

P356

P1433

Annals of the Rheumatic Diseases

P1476

HLA class I associations of an ...... pulation in the United Kingdom

@en

P2093

A Calin

http://www.w3.org/2001/XMLSchema#string

B P Wordsworth

http://www.w3.org/2001/XMLSchema#string

C Darke

http://www.w3.org/2001/XMLSchema#string

F Cornélis

http://www.w3.org/2001/XMLSchema#string

J Bell

http://www.w3.org/2001/XMLSchema#string

K D Pile

http://www.w3.org/2001/XMLSchema#string

L G Kennedy

http://www.w3.org/2001/XMLSchema#string

P2860

Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules

HLA-B alleles and complotypes in Mexican patients with seronegative spondyloarthropathies.

Ankylosing spondylitis and HL-A 27.

Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703.

HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients.

High association of an HL-A antigen, W27, with ankylosing spondylitis.

The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708).

HLA class I typing by PCR: HLA-B27 and an African B27 subtype

The Sensitivity of Single-Strand Conformation Polymorphism Analysis for the Detection of Single Base Substitutions

P304

268-270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.55.4.268

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Matthew A. Brown

P577

1996-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14469949

http://www.w3.org/2001/XMLSchema#string

P698

8733445

http://www.w3.org/2001/XMLSchema#string

P932

1010149

http://www.w3.org/2001/XMLSchema#string